MARCH6 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 7.120000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
9.343400E-01
Normal-vs-Stage2
6.401200E-01
Normal-vs-Stage3
4.304000E-01
Normal-vs-Stage4
8.943400E-01
Stage1-vs-Stage2
4.132200E-01
Stage1-vs-Stage3
1.616610E-01
Stage1-vs-Stage4
9.036400E-01
Stage2-vs-Stage3
3.017800E-01
Stage2-vs-Stage4
4.137200E-01
Stage3-vs-Stage4
2.613400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
7.092200E-01
Normal-vs-AfricanAmerican
9.804400E-01
Normal-vs-Asian
4.206000E-01
Caucasian-vs-AfricanAmerican
6.326000E-01
Caucasian-vs-Asian
3.785400E-01
AfricanAmerican-vs-Asian
2.920600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
6.659000E-01
Normal-vs-Female
7.886600E-01
Male-vs-Female
5.495400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
9.099800E-01
Normal-vs-Age(41-60Yrs)
9.075000E-01
Normal-vs-Age(61-80Yrs)
5.661600E-01
Normal-vs-Age(81-100Yrs)
3.589800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
7.744600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
6.942200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
3.817000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.622460E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
5.207700E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
3.822400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
4.058200E-01
Normal-vs-Daily Drinker
4.759800E-01
Normal-vs-Weekly Drinker
6.041200E-01
Normal-vs-Occasional Drinker
7.394600E-01
Normal-vs-Social Drinker
8.987600E-01
Non Drinker-vs-Daily Drinker
8.660600E-01
Non Drinker-vs-Weekly Drinker
6.877400E-01
Non Drinker-vs-Occasional Drinker
1.529740E-02
Non Drinker-vs-Social Drinker
7.917700E-02
Daily Drinker-vs-Weekly Drinker
8.106400E-01
Daily Drinker-vs-Occasional Drinker
3.539600E-02
Daily Drinker-vs-Social Drinker
1.368600E-01
Weekly Drinker-vs-Occasional Drinker
1.090760E-01
Weekly Drinker-vs-Social Drinker
2.794200E-01
Occasional Drinker-vs-Social Drinker
7.742400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.338000E-01
Normal-vs-Grade 2
4.717900E-02
Normal-vs-Grade 3
2.172000E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
7.778400E-01
Grade 1-vs-Grade 3
5.509400E-01
Grade 1-vs-Grade 4
2.338000E-01
Grade 2-vs-Grade 3
9.168200E-02
Grade 2-vs-Grade 4
4.717900E-02
Grade 3-vs-Grade 4
2.172000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.193800E-01
Normal-vs-NonDiabetic
7.136800E-01
Diabetic-vs-NonDiabetic
2.848000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
8.197600E-01
Normal-vs-NoPancreatitis
6.791000E-01
Pancreatitis-vs-NoPancreatitis
8.418000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
9.078800E-01
Normal-vs-N1
5.922400E-01
N0-vs-N1
3.121000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
8.071200E-01
Normal-vs-TP53-NonMutant
9.660600E-01
TP53-Mutant-vs-TP53-NonMutant
5.901600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
